Follow Us on Google+

Request A Price Quote:

NIIN Output Data

NIIN:
NSN:
Item Name:
BERACTANT INTRATRACHEAL SUSPENSI

Definition:

Reference/Part Number

Part Number CAGE Status RNCC RNVC DAC RNAAC MSDS SADC
SURVANTA 17550 A 5 9 4 KX
SURVANTA 23281 A 5 1 4 KX BXPDN
F93A339 66735 A 5 1 4 KX
NDC00074-1040-08 23281 A 3 2 4 KX
NDC00074-1040-08 17550 A 5 9 4 KX

CAGE Information

Code Company
17550 ROSS LABORATORIES INC.
23281 ABBOTT LABORATORIES INC ROSS PRODUCT
66735 AIR FORCE MEDICAL LOGISTICS OFFICE

Federal Supply Class

Title

DRUGS AND BIOLOGICALS

Inclusions:

INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.

Exclusions:

EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.

Characteristics (Decoded)

MRC Requirements Statement Clear Text Reply
CXCY PART NAME ASSIGNED BY CONTROLLING AGENCY BERACTANT INTRATRACHEAL SUSPENSION 8ML VIAL
CBBL FEATURES PROVIDED STERILE
AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 25.000 MILLIGRAMS PHOSPHOLIPIDS PER MILLILITER
CRLK PRIMARY CONTAINER CONTENT QUANTITY 8.000 MILLILITERS
FEAT SPECIAL FEATURES USED FOR PREVENTION AND TREATMENT OF RDS(HYALINE MEMBRANE DISEASE)IN PREMATURE INFANTS;NOTE:G;NOT FOR INJECTION
CQCT PRIMARY CONTAINER TYPE VIAL, SINGLE DOSE

Similar Parts

NDC00074-1040-08 , NDC00074104008 , 6505-01-372-0173 , 6505013720173 , 013720173 , SURVANTA , SURVANTA , F93A339 , NDC00074-1040-08 , NDC00074-1040-08 ,